Stuart A. Arbuckle
2012
In 2012, Stuart A. Arbuckle earned a total compensation of $4.8M as EVP & Chief Commercial Officer at Vertex Pharmaceuticals.
Compensation breakdown
| Bonus | $365,000 |
|---|---|
| Non-Equity Incentive Plan | $117,600 |
| Option Awards | $1,731,692 |
| Salary | $169,615 |
| Stock Awards | $2,131,308 |
| Other | $293,482 |
| Total | $4,808,697 |
Arbuckle received $2.1M in stock awards, accounting for 44% of the total pay in 2012.
Arbuckle also received $365K in bonus, $117.6K in non-equity incentive plan, $1.7M in option awards, $169.6K in salary and $293.5K in other compensation.
Rankings
In 2012, Stuart A. Arbuckle's compensation ranked 1,284th out of 11,487 executives tracked by ExecPay. In other words, Arbuckle earned more than 88.8% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 1,284 out of 11,487 | 89th |
Division Manufacturing | 462 out of 4,253 | 89th |
Major group Chemicals And Allied Products | 102 out of 1,198 | 92nd |
Industry group Drugs | 58 out of 920 | 94th |
Industry Pharmaceutical Preparations | 50 out of 700 | 93rd |
Source: SEC filing on April 30, 2015.
Arbuckle's colleagues
We found six more compensation records of executives who worked with Stuart A. Arbuckle at Vertex Pharmaceuticals in 2012.
2012
Matthew Emmens
Vertex Pharmaceuticals
Chief Executive Officer
2012
Jeffrey Leiden
Vertex Pharmaceuticals
Chief Executive Officer
2012
Peter Mueller
Vertex Pharmaceuticals
Chief Scientific Officer
2012
David Howton
Vertex Pharmaceuticals
Chief Legal Officer
2012
Ian Smith
Vertex Pharmaceuticals
Chief Financial Officer
2012
Kenneth Horton
Vertex Pharmaceuticals